Meeting
2023 ASCO Annual Meeting
Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).
Authors
Chris Alan Karlovich
Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD
Chris Alan Karlovich , Jennifer Silhavy , Jennifer S. LoCoco , Biswajit Das , Sorena Rahmanian , Ting-Chia Chang , Amanda Peach , Robin Harrington , Li Chen , Lyndsay Harris , Yao Fu , David R. Patton , Jessica Li , Alice P. Chen , Naoko Takebe , Traci L. Pawlowski , Lisa McShane , Phillip G. Febbo , James H. Doroshow , P. Mickey Williams
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2560)
DOI
10.1200/JCO.2023.41.16_suppl.2560
Abstract #
2560
Poster Bd #
402
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Molecular comparison of primary colorectal cancer (pCRC) with peritoneal metastases (PM).
First Author: Matthew K Stein
Poster
2017 ASCO Annual Meeting
Tumor mutational burden (TMB) and co-existing actionable mutations in biliary tract cancers (BTC).
First Author: Apurva Jain
Poster
2023 ASCO Annual Meeting
Gynecologic-cancer analysis of ARID1A alterations detected in tissue and liquid biopsies.
First Author: Natalie Danziger
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Immunohistochemistry-based molecular classification of gastric cancer in India: How are we different?
First Author: Biswajit Dubashi